CLINICAL AND ECONOMIC EVALUATION OF THROMBOPOIETIN RECEPTOR AGONISTS IN THE TREATMENT OF CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA IN ADULTS

Aim. Hospital-based economic analysis for the use of thrombopoietin receptor agonists (TRA) Eltrombopag and Romiplostim has been performed in patients with chronic idiopathic thrombocytopenic purpura (ITP) at the background failure of previous treatment options. Materials and methods. Two models for...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Prif Awduron: E. A. Pyadushkina, M. Yu. Frolov, M. V. Avksentyeva
Fformat: Artigo
Iaith:Russo
Cyhoeddwyd: IRBIS LLC 2016-02-01
Cyfres:Фармакоэкономика
Pynciau:
idiopathic thrombocytopenic purpura (itp)
cost-minimization analysis
budget impact analysis
thrombopoietin receptor agonist (tpo-ra)
eltrombopag
romiplostim
Mynediad Ar-lein:https://www.pharmacoeconomics.ru/jour/article/view/130
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg